Showing 1 - 10 of 117
This work examines the quality of the cost methods used to derive patient level costs in 45 economic evaluations conducted alongside randomised controlled trials. The perspective of the cost analysis, the methods used to determine quantities and values of resources and how the cost data were...
Persistent link: https://www.econbiz.de/10005689804
Persistent link: https://www.econbiz.de/10003439718
Persistent link: https://www.econbiz.de/10003439545
Persistent link: https://www.econbiz.de/10003632695
Persistent link: https://www.econbiz.de/10011416261
Persistent link: https://www.econbiz.de/10004367325
Persistent link: https://www.econbiz.de/10007909663
Introduction to economics of infectious disease / Jenny Roberts -- Choosing the first line drug for malaria treatment: how can cost-effectiveness analysis inform policy? / Catherine Goodman ... [et al.] -- Economic issues related to antimicrobial resistance / Ramanan Laxinarayan -- Economic...
Persistent link: https://www.econbiz.de/10013480070
This paper explores methodological and demographical reasons for differences in estimated social costs from foodborne Escherichia coli O157:H7 between the United States and United Kingdom (UK). Depending on the evaluation method, estimated U.S. costs average $10,000-17,000/case while estimated...
Persistent link: https://www.econbiz.de/10005501174
Funds to promote access to water and sanitation in developing countries are scarce and most of the investments come from the national governments and households sources, not international resources. In many of these countries, mainly in middle income countries, households are paying direct taxes...
Persistent link: https://www.econbiz.de/10009023765